Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Completed · Phase 2
Conditions studied: Atopic Dermatitis
In brief
This is a double-blind, multi-centre, randomised, 5-arm, vehicle-controlled, parallel-group trial. The trial is designed to establish a dose-response signal and investigate the efficacy and safety of delgocitinib cream in the treatment of adult subjects with mild to severe atopic dermatitis (AD).
Key facts
- Study ID
- NCT03725722
- Run by
- LEO Pharma
- People needed
- 251
- Starts
- 2018-12-28
- Expected to finish
- 2020-05-19
- Last updated by the study team
- 2025-03-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Leo Pharma Investigational Site — Birmingham, Alabama, United States
- Leo Pharma Investigational Site — Encino, California, United States
- Leo Pharma Investigational Site — Los Angeles, California, United States
- Leo Pharma Investigational Site — Los Angeles, California, United States
- Leo Pharma Investigational Site — Rolling Hills Estates, California, United States
- Leo Pharma Investigational Site — Santa Ana, California, United States
- Leo Pharma Investigational Site — Chicago, Illinois, United States
- Leo Pharma Investigational Site — Detroit, Michigan, United States
- Leo Pharma Investigational Site — New York, New York, United States
- Leo Pharma Investigational Site — High Point, North Carolina, United States
- Leo Pharma Investigational Site — Philadelphia, Pennsylvania, United States
- Leo Pharma Investigational Site — Carlton, Australia
- Leo Pharma Investigational Site — Darlinghurst, Australia
- Leo Pharma Investigational Site — East Melbourne, Australia
- Leo Pharma Investigational Site — Hectorville, Australia
- Leo Pharma Investigational Site 1 — Kogarah, Australia
- Leo Pharma Investigational Site — Kogarah, Australia
- Leo Pharma Investigational Site — Woolloongabba, Australia
- Leo Pharma Investigational Site — Calgary, Alberta, Canada
- Leo Pharma Investigational Site — Edmonton, Alberta, Canada
- Leo Pharma Investigational Site — Surrey, British Columbia, Canada
- Leo Pharma Investigational Site — Winnipeg, Manitoba, Canada
- Leo Pharma Investigational Site — Fredericton, New Brunswick, Canada
- Leo Pharma Investigational Site — Mississauga, Ontaria, Canada
- Leo Pharma Investigational Site — Barrie, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.